Health & Nutrition

bg
Florida law models what genetic disease testing could be

Florida law models what genetic disease testing could be

A Florida state legislator sponsored the nation's first state-backed genetic screening...

bg
Moderna says FDA refuses to review its application for experimental flu shot

Moderna says FDA refuses to review its application for...

Moderna said the move is inconsistent with previous feedback from the FDA on the...

bg
Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs

Novo Nordisk CEO sees 15 million patient opportunity in...

Doustdar said Medicare coverage and the launch of Novo's new obesity pill should...

bg
How the largest health-care education company in U.S. is addressing a growing jobs gap

How the largest health-care education company in U.S. is...

Adtalem Global Education changed its name to Covista last week, a move the company...

bg
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start

Novo Nordisk faces a defining year in the obesity drug...

The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but...

bg
Which Foods Help a Leaky Gut?

Which Foods Help a Leaky Gut?

What is the recommended diet for treating leaky gut? Which foods and food components...

bg
Nuts, Sperm, and Sex: The Surprising Connection

Nuts, Sperm, and Sex: The Surprising Connection

Walnuts, almonds, and hazelnuts are put to the test for erectile and sexual function,...

bg
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Healthy Returns: Pfizer execs chart out obesity strategy...

Pfizer made one thing clear this week: It's officially back in the obesity race. 

bg
Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers pulls copycat weight-loss pill after threats...

Hims & Hers on Saturday announced it would stop offering its copycat of the...

bg
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats quarterly estimates despite Covid product...

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors...